Within the International Operations Department at HQ, responsible for the coordination of all the medical affair activities for 24 countries in Europe, Canada, Australia, Russia, Turkey and Asia.• Accredited and non-accredited continuous medical education for physicians. Participation to the face-to-face medical training during the lab visits.• Train the trainer (ambassador) program for participants from 13 countries• Face-to-face or web training on the pathology and the products for Medical reps, medical advisors, and general managers.• KOL management with mapping and engagement plans.• Advisory boards; selection of members, meetings, action plan, deliverables.• Clinical studies: Phase IV, NIS and ISS.• Scientific communication: scientific articles, oral communications in congresses and company sponsored symposium, presentation of abstracts and posters in international congresses.• Monitoring and analysis of the medical literature, selection of key articles and preparation of the communication material in collaboration with marketing team.• Review of promotional material for medical and scientific messages.• Answer to medical information questions from HCPs.• Medical support for day-to-day activities of affiliates, and for the development of their local Medical Affairs plan.• Management of the International Operations Department budget for medical activities.• Management of the current Medical network and the affiliate Medical Directors / Advisors, with the responsibility of developing the international medical network. Involvement in the recruitment of MSLs.

Responsible for• the definition of the global strategic plan for all interventional and non-interventional post-marketing authorization studies and investigator-sponsored studies.• the supervision and coordination of all post-marketing authorization studies carried out by corporate or by affiliates.• the review and approval of all new projects.Member of project and product teams for the development of new products and the life cycle management of products already on the market.Medical training on disease and products for internal staff and external stakeholders (KOL, physicians).

In charge of the clinical development plan for a new immunotherapy tablet in birch pollen allergyPreparation and conduct of the Phase I and Phase II studies.Preparation of 2 aborted projects (1 Phase II and 1 Phase III)Preparation, submission and set-up of a Phase IIIbPreparation of 2 Scientific Advices at the EMEA on clinical development issues. Preparation of the PIP.Participation in the clinical development plan and strategic options.Member of the Project Team and Steering Committee.Set-up of an independent expert board for clinical development of birch pollen immunotherapy.Preparation and review of abstracts and publication on study results.Oral presentations in national and international congresses.

In charge of• 5 ancillary projects of a mega-trial in stroke prevention. Each project being implemented in 16 to 38 countries worldwide with a recruitment of 1 000 to 12 000 patients.• A clinical pharmacology phase II study• A phase I study